EIKN · Eikon Therapeutics, Inc.
$9.62
+0.01 (+0.10%)
At close · Jul 23
Market Cap
$520.81M
Shares
54.14M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.62
Open$9.37
Day$9.15–9.81
52W$7.90–17.40
Avg vol 30d401K
Short int4.6M · 8.6% float · 7.9d
Short vol71%
DataFeb 2026–Jul 2026
Filing10-Q · May 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−8%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
18%
mid-range
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
5 of 51 funds reported for Jun 30 · net +7.6K sh shares · +5 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
8.55% of float · ▲ +2.8% MoM · 7.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
51 holders — 13F breadth
Squeeze score
68
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
93%
annualized · 1-yr
Max drawdown
−49%
past year
ATR
8.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−8%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
18%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
5 of 51 funds reported for Jun 30 · net +7.6K sh shares · +5 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
8.55% of float · ▲ +2.8% MoM · 7.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
51 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $8
Now $10 · 18%
52-wk high $17
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EIKN
this stock
Eikon Therapeutics, Inc.
|
$520.81M | — | — | — | 8.6% |
|
ONC
BeOne Medicines Ltd.
|
$472.27B | +7.6% | +22179.2% | 961.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$120.07B | +4.4% | +46.2% | 28.1 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.35B | -15.4% | +20.8% | 15.9 | 3.3% |
|
ARGX
Argenx SE
|
$57.84B | +9.9% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EIKN | -3.3% | -0.1% | — | -26.3% | — |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -1.7% | -0.8% | — | -25.1% | — |